Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure
- 3 February 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 130 (5) , 741-759
Abstract
Background: Abnormalities in cardiac energy metabolism occur in heart failure (HF) and contribute to contractile dysfunction, but their role, if any, in HF-related pathologic remodeling is much less established. CK (creatine kinase), the primary muscle energy reserve reaction which rapidly provides ATP at the myofibrils and regenerates mitochondrial ADP, is down-regulated in experimental and human HF. To test the hypotheses that pathologic remodeling in human HF is related to impaired cardiac CK energy metabolism and that rescuing CK attenuates maladaptive hypertrophy in experimental HF. Methods: First, in 27 HF patients and 14 healthy subjects, we measured cardiac energetics and left ventricular remodeling using noninvasive magnetic resonance 31P spectroscopy and magnetic resonance imaging, respectively. Second, we tested the impact of metabolic rescue with cardiac-specific overexpression of either Ckmyofib (myofibrillar CK) or Ckmito (mitochondrial CK) on HF-related maladaptive hypertrophy in mice. Results: In people, pathologic left ventricular hypertrophy and dilatation correlate closely with reduced myocardial ATP levels and rates of ATP synthesis through CK. In mice, transverse aortic constriction-induced left ventricular hypertrophy and dilatation are attenuated by overexpression of CKmito, but not by overexpression of CKmyofib. CKmito overexpression also attenuates hypertrophy after chronic isoproterenol stimulation. CKmito lowers mitochondrial reactive oxygen species, tissue reactive oxygen species levels, and upregulates antioxidants and their promoters. When the CK capacity of CKmito-overexpressing mice is limited by creatine substrate depletion, the protection against pathologic remodeling is lost, suggesting the ADP regenerating capacity of the CKmito reaction rather than CK protein per se is critical in limiting adverse HF remodeling. Conclusions: In the failing human heart, pathologic hypertrophy and adverse remodeling are closely related to deficits in ATP levels and in the CK energy reserve reaction. CKmito, sitting at the intersection of cardiac energetics and redox balance, plays a crucial role in attenuating pathologic remodeling in HF. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00181259.Keywords
This publication has 79 references indexed in Scilit:
- FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc functionThe EMBO Journal, 2011
- Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2 Emission from Isolated Heart MitochondriaJournal of Biological Chemistry, 2011
- The creatine kinase system and pleiotropic effects of creatineAmino Acids, 2011
- Reduced in vivo high-energy phosphates precede Adriamycin-induced cardiac dysfunctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Triple repetition time saturation transfer (TRiST) 31P spectroscopy for measuring human creatine kinase reaction kineticsMagnetic Resonance in Medicine, 2010
- Energetic performance is improved by specific activation of K+ fluxes through KCa channels in heart mitochondriaBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Correcting reaction rates measured by saturation-transfer magnetic resonance spectroscopyJournal of Magnetic Resonance, 2008
- Induction of Mxi1-SRα by FOXO3a Contributes to Repression of Myc-Dependent Gene ExpressionMolecular and Cellular Biology, 2007
- Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2‐dependent pathwayThe EMBO Journal, 2006
- Oxidative stress and redox signalling in cardiac hypertrophy and heart failureHeart, 2006